Ims Health Holdings Inc. (IMS) 29.28 $IMS
InsiderInsights.com Daily Round Up 5/13/15: LJPC, LIFE, HTGM, COLL
InsiderInsights - at Seeking Alpha - Thu May 14, 11:13AM CDT
ROP: 176.35 (+2.18), IMDZ: 21.29 (-0.50), LIFE: 20.58 (+0.99), LJPC: 19.80 (+0.88), TROX: 18.57 (+0.14), COLL: 14.90 (+1.65), DIS: 109.93 (+0.74), SNI: 66.14 (-0.37), ADPT: 63.59 (-0.86), OZRK: 42.56 (+0.62), AMRC: 7.24 (+0.27), IMS: 29.28 (+0.33), GCI: 35.59 (+0.75), RESI: 18.90 (+0.90), HTGM: 14.36 (+0.18), DYN: 32.40 (+0.02), HRG: 12.39 (+0.06)
SAIC to Offer Public Safety Support Services Across the US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 13, 3:05PM CDT
Science Applications International Corporation (SAIC) recently secured yet another contract from the Space and Naval Warfare Systems Center Pacific (SPAWAR).
IMS: 29.28 (+0.33), SAIC: 53.22 (+1.30), CUDA: 39.16 (-0.29), CDW: 37.37 (+0.38)
IMS Health Announces Closing of Secondary Public Offering and Repurchase of Common Stock
Business Wire - Tue May 12, 3:40PM CDT
IMS Health Holdings, Inc. ("IMS Health"
(NYSE:IMS) today announced the closing of its secondary public offering of approximately 58 million shares of its common stock by existing shareholders affiliated with TPG Global, LLC, Canada Pension Plan Investment Board and Leonard Green & Partners, L.P., at a price to the public of $27.50 per share. The offering included 6.87 million shares sold in connection with the full exercise of the option to purchase additional shares granted to the underwriters. Of the approximately 58 million shares sold in the offering, about 11.1 million shares were repurchased by IMS Health at a price per share of $27.0875, which is equal to the midpoint between the public offering price and the price to the selling shareholders in the offering. IMS Health did not offer any stock in this transaction and did not receive any proceeds from the sale of the shares by the selling shareholders.
IMS: 29.28 (+0.33), FITB: 20.62 (+0.13), JPM: 66.05 (+0.53)
What Everybody Ought to Know: Complementary Research on Marchex, Yelp Inc., IMS Health, InterCloud Systems and Teradata Corporation
PR Newswire - Tue May 12, 8:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
IMS: 29.28 (+0.33), TDC: 40.82 (+0.18), ICLD: 3.74 (-0.20), YELP: 47.35 (-0.49), MCHX: 5.04 (-0.08)
Science Applications (SAIC) Secures a New Contract - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 08, 4:17PM CDT
Science Applications International Corp. (SAIC) recently secured a task order worth approximately $118.5 million to provide fleet deployment training program support to the U.S. Fleet Forces Command.
CSGP: 209.65 (+4.47), IMS: 29.28 (+0.33), SAIC: 53.22 (+1.30), CUDA: 39.16 (-0.29)
IMS shareholders head for the exits
Seeking Alpha - at Seeking Alpha - Wed May 06, 7:01PM CDT
IMS: 29.28 (+0.33)
IMS Health Announces Pricing of Secondary Public Offering and Repurchase of Common Stock
Business Wire - Wed May 06, 6:21PM CDT
IMS Health Holdings, Inc. ("IMS Health" (NYSE:IMS) today announced the pricing of its secondary public offering of 51.1 million shares of its common stock, increased from 45.8 million shares, by existing shareholders affiliated with TPG Global, LLC, Canada Pension Plan Investment Board and Leonard Green & Partners, L.P., at a price to the public of $27.50. Of the 51.1 million shares in this offering, IMS Health intends to repurchase approximately 11.1 million shares at a price per share of $27.0875, which is equal to the midpoint between the public offering price and the price to the selling shareholders in this offering. The selling shareholders have granted the underwriters an option to purchase up to an additional 6.87 million shares of common stock. IMS Health is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the selling shareholders. The offering is expected to close on May 12, 2015, subject to customary closing conditions.
IMS: 29.28 (+0.33), FITB: 20.62 (+0.13), JPM: 66.05 (+0.53)
IMS Health Acquires Dataline Software, Extending Real-World Evidence Technology Platform and Application Suite
Business Wire - Wed May 06, 6:00AM CDT
IMS Health (NYSE:IMS) has acquired Dataline Software, a leader in Big Data analytics for healthcare, to extend its technology-enabled Real-World Evidence (RWE) platform and accelerate delivery of integrated clinical and cost-of-care insights for assessing healthcare value and performance. Dataline's powerful software tools significantly expand the capabilities of Evidence 360(TM), IMS Health's scalable and secure RWE platform that helps clients extract, analyze and visualize real-world data to better understand and measure healthcare outcomes.
IMS: 29.28 (+0.33)
IMS Health Finds Global Cancer Drug Spending Crossed $100 Billion Threshold in 2014
Business Wire - Tue May 05, 6:43AM CDT
--Higher Prevalence of Cancers, Earlier Treatments, Innovative Therapies,
IMS: 29.28 (+0.33)
IMS Health Announces Launch of Secondary Public Offering and Repurchase of Common Stock
Business Wire - Mon May 04, 3:22PM CDT
IMS Health Holdings, Inc. ("IMS Health" (NYSE:IMS) today announced the launch of a secondary public offering of 45.8 million shares of its common stock by existing shareholders affiliated with TPG Global, LLC, Canada Pension Plan Investment Board and Leonard Green & Partners, L.P., of which IMS Health intends to repurchase a number of shares having an aggregate value of $300 million. The selling shareholders have granted the underwriters an option to purchase up to an additional 6.87 million shares of common stock. IMS Health is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the selling shareholders.
IMS: 29.28 (+0.33), FITB: 20.62 (+0.13), JPM: 66.05 (+0.53)
IMS Health Finds Wide Disparity Between Essential Medicines List of WHO and Several Pharmerging Countries
Business Wire - Thu Apr 30, 10:00AM CDT
The high level of disparity between the World Health Organization's Model Essential Medicines List (EML) and the EMLs of nine pharmerging countries was highlighted in remarks by Murray Aitken, executive director of the IMS Institute for Healthcare Informatics, at the WHO's Expert Committee session on April 20. At the Geneva meeting, Aitken presented findings from Understanding the Role and Use of Essential Medicines Lists, an IMS Institute report that reviewed and compared national lists of medicines in Brazil, China, India, Indonesia, Kenya, Malawi, Philippines, South Africa and Tanzania.
IMS: 29.28 (+0.33)
Earnings Update: Complementary Research on Healthways Inc., eHealth, Marketo, IMS Health, Microsemi
PR Newswire - Wed Apr 29, 7:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
IMS: 29.28 (+0.33), HWAY: 17.30 (-0.14), MSCC: 33.80 (+0.20), MKTO: 29.58 (+0.15), EHTH: 12.81 (+0.40)
IMS Health Bounces Back With A Strong Q1
Dallas Salazar - at Seeking Alpha - Mon Apr 27, 9:10AM CDT
MPG: 19.10 (-0.09), IMS: 29.28 (+0.33), AXTA: 33.78 (+0.48)
4 Top-Rated Drugmakers Reporting Earnings This Week
at Investor's Business Daily - Sun Apr 26, 7:02AM CDT
This week will bring first-quarter earnings reports from four top-rated large-cap drug stocks, and each is expected to report strong growth. On Tuesday before the open, United Therapeutics (UTHR) is expected to report revenue of $353.5 million, up...
IMS: 29.28 (+0.33), VRX: 222.82 (+2.92), GILD: 108.74 (+2.35), AZN: 70.10 (+0.75), UTHR: 173.53 (-1.94), ABBV: 65.97 (+0.67), CELG: 115.08 (+1.68)
IMS Health Holdings' (IMS) CEO Ari Bousbib on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Apr 24, 2:28PM CDT
IMS: 29.28 (+0.33)
IMS Health beats Street 1Q forecasts
Automated Insights - Fri Apr 24, 6:43AM CDT
DANBURY, Conn. (AP) _ IMS Health Holdings Inc. (IMS) on Friday reported first-quarter net income of $298 million, after reporting a loss in the same period a year earlier.
IMS: 29.28 (+0.33)
IMS Health beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 6:05AM CDT
IMS: 29.28 (+0.33)
IMS Health Reports First-Quarter 2015 Results
Business Wire - Fri Apr 24, 6:00AM CDT
--Adjusted EBITDA up 9.8 percent at constant currency
IMS: 29.28 (+0.33)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 4:30PM CDT
BIIB: 394.35 (+4.31), SPG: 184.76 (+3.42), B: 40.70 (+0.85), INFY: 30.70 (-0.05), VTR: 68.20 (+1.11), AOS: 69.49 (+0.51), LYB: 104.21 (-0.19), COG: 35.32 (+0.20), AJG: 48.36 (+0.07), AAL: 48.81 (+0.32), AAN: 34.75 (-0.35), AVX: 14.51 (+0.34), TYC: 39.61 (+0.33), STT: 77.72 (-0.28), FNFG: 8.98 (-0.03), IMGN: 8.55 (-0.57), IPG: 21.14 (+0.34), XRX: 11.30 (+0.06), DTE: 78.09 (+0.90), LEA: 114.42 (+0.28), FLIR: 31.92 (+0.12), IMS: 29.28 (+0.33), SHOO: 38.78 (+0.33), OFG: 13.25 (+0.04), AZN: 70.10 (+0.75), PB: 54.03 (+0.10), EHTH: 12.81 (+0.40)
InsiderInsights.com Daily Round Up 5/13/15: LJPC, LIFE, HTGM, COLL
InsiderInsights - at Seeking Alpha - Thu May 14, 11:13AM CDT
ROP: 176.35 (+2.18), IMDZ: 21.29 (-0.50), LIFE: 20.58 (+0.99), LJPC: 19.80 (+0.88), TROX: 18.57 (+0.14), COLL: 14.90 (+1.65), DIS: 109.93 (+0.74), SNI: 66.14 (-0.37), ADPT: 63.59 (-0.86), OZRK: 42.56 (+0.62), AMRC: 7.24 (+0.27), IMS: 29.28 (+0.33), GCI: 35.59 (+0.75), RESI: 18.90 (+0.90), HTGM: 14.36 (+0.18), DYN: 32.40 (+0.02), HRG: 12.39 (+0.06)
SAIC to Offer Public Safety Support Services Across the US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 13, 3:05PM CDT
Science Applications International Corporation (SAIC) recently secured yet another contract from the Space and Naval Warfare Systems Center Pacific (SPAWAR).
IMS: 29.28 (+0.33), SAIC: 53.22 (+1.30), CUDA: 39.16 (-0.29), CDW: 37.37 (+0.38)
IMS Health Announces Closing of Secondary Public Offering and Repurchase of Common Stock
Business Wire - Tue May 12, 3:40PM CDT
IMS Health Holdings, Inc. ("IMS Health"
(NYSE:IMS) today announced the closing of its secondary public offering of approximately 58 million shares of its common stock by existing shareholders affiliated with TPG Global, LLC, Canada Pension Plan Investment Board and Leonard Green & Partners, L.P., at a price to the public of $27.50 per share. The offering included 6.87 million shares sold in connection with the full exercise of the option to purchase additional shares granted to the underwriters. Of the approximately 58 million shares sold in the offering, about 11.1 million shares were repurchased by IMS Health at a price per share of $27.0875, which is equal to the midpoint between the public offering price and the price to the selling shareholders in the offering. IMS Health did not offer any stock in this transaction and did not receive any proceeds from the sale of the shares by the selling shareholders. IMS: 29.28 (+0.33), FITB: 20.62 (+0.13), JPM: 66.05 (+0.53)
What Everybody Ought to Know: Complementary Research on Marchex, Yelp Inc., IMS Health, InterCloud Systems and Teradata Corporation
PR Newswire - Tue May 12, 8:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
IMS: 29.28 (+0.33), TDC: 40.82 (+0.18), ICLD: 3.74 (-0.20), YELP: 47.35 (-0.49), MCHX: 5.04 (-0.08)
Science Applications (SAIC) Secures a New Contract - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 08, 4:17PM CDT
Science Applications International Corp. (SAIC) recently secured a task order worth approximately $118.5 million to provide fleet deployment training program support to the U.S. Fleet Forces Command.
CSGP: 209.65 (+4.47), IMS: 29.28 (+0.33), SAIC: 53.22 (+1.30), CUDA: 39.16 (-0.29)
IMS shareholders head for the exits
Seeking Alpha - at Seeking Alpha - Wed May 06, 7:01PM CDT
IMS: 29.28 (+0.33)
IMS Health Announces Pricing of Secondary Public Offering and Repurchase of Common Stock
Business Wire - Wed May 06, 6:21PM CDT
IMS Health Holdings, Inc. ("IMS Health"
(NYSE:IMS) today announced the pricing of its secondary public offering of 51.1 million shares of its common stock, increased from 45.8 million shares, by existing shareholders affiliated with TPG Global, LLC, Canada Pension Plan Investment Board and Leonard Green & Partners, L.P., at a price to the public of $27.50. Of the 51.1 million shares in this offering, IMS Health intends to repurchase approximately 11.1 million shares at a price per share of $27.0875, which is equal to the midpoint between the public offering price and the price to the selling shareholders in this offering. The selling shareholders have granted the underwriters an option to purchase up to an additional 6.87 million shares of common stock. IMS Health is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the selling shareholders. The offering is expected to close on May 12, 2015, subject to customary closing conditions. IMS: 29.28 (+0.33), FITB: 20.62 (+0.13), JPM: 66.05 (+0.53)
IMS Health Acquires Dataline Software, Extending Real-World Evidence Technology Platform and Application Suite
Business Wire - Wed May 06, 6:00AM CDT
IMS Health (NYSE:IMS) has acquired Dataline Software, a leader in Big Data analytics for healthcare, to extend its technology-enabled Real-World Evidence (RWE) platform and accelerate delivery of integrated clinical and cost-of-care insights for assessing healthcare value and performance. Dataline's powerful software tools significantly expand the capabilities of Evidence 360(TM), IMS Health's scalable and secure RWE platform that helps clients extract, analyze and visualize real-world data to better understand and measure healthcare outcomes.
IMS: 29.28 (+0.33)
IMS Health Finds Global Cancer Drug Spending Crossed $100 Billion Threshold in 2014
Business Wire - Tue May 05, 6:43AM CDT
--Higher Prevalence of Cancers, Earlier Treatments, Innovative Therapies,
IMS: 29.28 (+0.33)
IMS Health Announces Launch of Secondary Public Offering and Repurchase of Common Stock
Business Wire - Mon May 04, 3:22PM CDT
IMS Health Holdings, Inc. ("IMS Health"
(NYSE:IMS) today announced the launch of a secondary public offering of 45.8 million shares of its common stock by existing shareholders affiliated with TPG Global, LLC, Canada Pension Plan Investment Board and Leonard Green & Partners, L.P., of which IMS Health intends to repurchase a number of shares having an aggregate value of $300 million. The selling shareholders have granted the underwriters an option to purchase up to an additional 6.87 million shares of common stock. IMS Health is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the selling shareholders. IMS: 29.28 (+0.33), FITB: 20.62 (+0.13), JPM: 66.05 (+0.53)
IMS Health Finds Wide Disparity Between Essential Medicines List of WHO and Several Pharmerging Countries
Business Wire - Thu Apr 30, 10:00AM CDT
The high level of disparity between the World Health Organization's Model Essential Medicines List (EML) and the EMLs of nine pharmerging countries was highlighted in remarks by Murray Aitken, executive director of the IMS Institute for Healthcare Informatics, at the WHO's Expert Committee session on April 20. At the Geneva meeting, Aitken presented findings from Understanding the Role and Use of Essential Medicines Lists, an IMS Institute report that reviewed and compared national lists of medicines in Brazil, China, India, Indonesia, Kenya, Malawi, Philippines, South Africa and Tanzania.
IMS: 29.28 (+0.33)
Earnings Update: Complementary Research on Healthways Inc., eHealth, Marketo, IMS Health, Microsemi
PR Newswire - Wed Apr 29, 7:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
IMS: 29.28 (+0.33), HWAY: 17.30 (-0.14), MSCC: 33.80 (+0.20), MKTO: 29.58 (+0.15), EHTH: 12.81 (+0.40)
IMS Health Bounces Back With A Strong Q1
Dallas Salazar - at Seeking Alpha - Mon Apr 27, 9:10AM CDT
MPG: 19.10 (-0.09), IMS: 29.28 (+0.33), AXTA: 33.78 (+0.48)
4 Top-Rated Drugmakers Reporting Earnings This Week
at Investor's Business Daily - Sun Apr 26, 7:02AM CDT
This week will bring first-quarter earnings reports from four top-rated large-cap drug stocks, and each is expected to report strong growth. On Tuesday before the open, United Therapeutics (UTHR) is expected to report revenue of $353.5 million, up...
IMS: 29.28 (+0.33), VRX: 222.82 (+2.92), GILD: 108.74 (+2.35), AZN: 70.10 (+0.75), UTHR: 173.53 (-1.94), ABBV: 65.97 (+0.67), CELG: 115.08 (+1.68)
IMS Health Holdings' (IMS) CEO Ari Bousbib on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Apr 24, 2:28PM CDT
IMS: 29.28 (+0.33)
IMS Health beats Street 1Q forecasts
Automated Insights - Fri Apr 24, 6:43AM CDT
DANBURY, Conn. (AP) _ IMS Health Holdings Inc. (IMS) on Friday reported first-quarter net income of $298 million, after reporting a loss in the same period a year earlier.
IMS: 29.28 (+0.33)
IMS Health beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 6:05AM CDT
IMS: 29.28 (+0.33)
IMS Health Reports First-Quarter 2015 Results
Business Wire - Fri Apr 24, 6:00AM CDT
--Adjusted EBITDA up 9.8 percent at constant currency
IMS: 29.28 (+0.33)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 4:30PM CDT
BIIB: 394.35 (+4.31), SPG: 184.76 (+3.42), B: 40.70 (+0.85), INFY: 30.70 (-0.05), VTR: 68.20 (+1.11), AOS: 69.49 (+0.51), LYB: 104.21 (-0.19), COG: 35.32 (+0.20), AJG: 48.36 (+0.07), AAL: 48.81 (+0.32), AAN: 34.75 (-0.35), AVX: 14.51 (+0.34), TYC: 39.61 (+0.33), STT: 77.72 (-0.28), FNFG: 8.98 (-0.03), IMGN: 8.55 (-0.57), IPG: 21.14 (+0.34), XRX: 11.30 (+0.06), DTE: 78.09 (+0.90), LEA: 114.42 (+0.28), FLIR: 31.92 (+0.12), IMS: 29.28 (+0.33), SHOO: 38.78 (+0.33), OFG: 13.25 (+0.04), AZN: 70.10 (+0.75), PB: 54.03 (+0.10), EHTH: 12.81 (+0.40)
